Connect your AI

Catalyst Pharmaceutical CPRX Net debt

Discontinued — last reported Q1 '26

Net debt at other companies

Graphic Packaging HoldingGPK

4.5×+0.9×

MattelMAT

2.8×+1.1×

Dorman ProductsDORM

1.5×+0.1×

International Seaways, Inc.INSW

0.6×-0.3×

Inter ParfumsIPAR

0.2×0.0×

Centrus EnergyLEU

-16.8×-21.3×

Other financials

Income statement

Revenue$149.4M+5.6%

Gross profit$134.9M+9.2%

Operating income$73.2M+15.6%

Net income$63.7M+12.3%

EPS (diluted)$0.50+11.1%

Balance sheet

Cash & equivalents$755.9M+30.2%

Total debt$2.7M-13.3%

Total equity$1.0B+27.5%

Total assets$1.1B+26.3%

Cash flow

Operating cash flow$59.6M-0.8%

CapEx$27.0K—

Free cash flow$59.6M-0.8%

Valuation

Market cap$3.84B+2.7%

Profitability

Gross margin86%-0.2pp

Operating margin44.8%+1.6pp

Net margin37.1%+0.2pp

FCF margin34.9%-15.2pp

Returns & leverage

Return on equity24.5%-4.6pp

Debt / equity0×0.0×

Current ratio7.1×+1.0×

Where this comes from

Calculated from Catalyst Pharmaceutical’s reported figures.

$2.7Mtotal debt−$755.9Mcash and equivalents=-$753.18M

The official record: Catalyst Pharmaceutical’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Catalyst Pharmaceutical's net debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Catalyst Pharmaceutical's net debt?: Catalyst Pharmaceutical (CPRX) reported net debt of -$753.18M in Q1 2026.
How has Catalyst Pharmaceutical's net debt changed year-over-year?: Catalyst Pharmaceutical's net debt decreased by 30.4% year-over-year, from -$577.57M to -$753.18M.
What is the long-term trend for Catalyst Pharmaceutical's net debt?: Over 5 years (2020 to 2025), Catalyst Pharmaceutical's net debt has grown at a 40.2% compound annual growth rate (CAGR), from -$130.21M to -$706.38M.
What does net debt mean?: Total debt minus cash and equivalents at the quarter end. The debt that would remain if the company used all its cash to pay down borrowings.